Literature DB >> 24040617

Utility of ADC measurement on diffusion-weighted MRI in differentiation of prostate cancer, normal prostate and prostatitis.

Meltem Esen1, Mehmet Ruhi Onur, Nusret Akpolat, Irfan Orhan, Ercan Kocakoc.   

Abstract

To determine the utility of apparent diffusion coefficient (ADC) values in differentiation of prostate cancer from normal prostate parenchyma and prostatitis we obtained ADC values of 50 patients at b 100, 600 and 1,000 s/mm(2) diffusion gradients. The ADC values of prostate cancer group were significantly lower than normal prostate and prostatitis group at b 600 and 1,000 s/mm(2) gradients. The ADC values at high diffusion gradients may be used in differentiation prostate cancer from normal prostate and prostatitis.

Entities:  

Keywords:  Diffusion-weighted MR imaging; apparent diffusion coefficient (ADC); prostate cancer; prostatitis

Year:  2013        PMID： 24040617      PMCID： PMC3759138          DOI： 10.3978/j.issn.2223-4292.2013.08.06

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN： 2223-4306


  20 in total

Review 1.  Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries.

Authors:  M Quinn; P Babb
Journal:  BJU Int       Date:  2002-07       Impact factor: 5.588

2.  Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer.

Authors:  D Svetec; K McCabe; S Peretsman; E Klein; H Levin; S Optenberg; I Thompson
Journal:  J Urol       Date:  1998-05       Impact factor: 7.450

Review 3.  A clinically relevant approach to imaging prostate cancer: review.

Authors:  Sadhna Verma; Arumugam Rajesh
Journal:  AJR Am J Roentgenol       Date:  2011-03       Impact factor: 3.959

4.  Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T.

Authors:  Klaas N A Nagel; Martijn G Schouten; Thomas Hambrock; Geert J S Litjens; Caroline M A Hoeks; Bennie ten Haken; Jelle O Barentsz; Jurgen J Fütterer
Journal:  Radiology       Date:  2013-01-17       Impact factor: 11.105

5.  Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions.

Authors:  Frank H Miller; Nancy Hammond; Aheed J Siddiqi; Sagar Shroff; Gaurav Khatri; Yi Wang; Laura B Merrick; Paul Nikolaidis
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

6.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.

Authors:  D Le Bihan; E Breton; D Lallemand; M L Aubin; J Vignaud; M Laval-Jeantet
Journal:  Radiology       Date:  1988-08       Impact factor: 11.105

7.  Diffusion-weighted MRI in the evaluation of renal lesions: preliminary results.

Authors:  M Cova; E Squillaci; F Stacul; G Manenti; S Gava; G Simonetti; R Pozzi-Mucelli
Journal:  Br J Radiol       Date:  2004-10       Impact factor: 3.039

8.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging.

Authors:  Bashar Issa
Journal:  J Magn Reson Imaging       Date:  2002-08       Impact factor: 4.813

9.  Correlation of diffusion-weighted MRI with whole mount radical prostatectomy specimens.

Authors:  N Van As; E Charles-Edwards; A Jackson; S Jhavar; S Reinsberg; N Desouza; D Dearnaley; M Bailey; A Thompson; T Christmas; C Fisher; C Corbishley; S Sohaib
Journal:  Br J Radiol       Date:  2008-06       Impact factor: 3.039

10.  Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging.

Authors:  Tejas Parikh; Stephen J Drew; Vivian S Lee; Samson Wong; Elizabeth M Hecht; James S Babb; Bachir Taouli
Journal:  Radiology       Date:  2008-01-25       Impact factor: 11.105
View more
  12 in total

1.  Assessment of prostate imaging reporting and data system version 2.1 false-positive category 4 and 5 lesions in clinically significant prostate cancer.

Authors:  Xiangyu Wang; Weizong Liu; Yi Lei; Guangyao Wu; Fan Lin
Journal:  Abdom Radiol (NY)       Date:  2021-03-12

2.  [Value of PI-RADS v2 scores combined with prostate specific antigen in diagnosis of peripheral zone prostate cancer: a logistic regression analysis].

Authors:  Li-Zhi Lei; Yi-Kai Xu; Mei-Rong Hou; Meng-Qi He
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-08-20

3.  Development of a Combined MR Fingerprinting and Diffusion Examination for Prostate Cancer.

Authors:  Alice C Yu; Chaitra Badve; Lee E Ponsky; Shivani Pahwa; Sara Dastmalchian; Matthew Rogers; Yun Jiang; Seunghee Margevicius; Mark Schluchter; William Tabayoyong; Robert Abouassaly; Debra McGivney; Mark A Griswold; Vikas Gulani
Journal:  Radiology       Date:  2017-02-10       Impact factor: 11.105

Review 4.  Multiparametric MRI in prostate cancer management.

Authors:  Linda M Johnson; Baris Turkbey; William D Figg; Peter L Choyke
Journal:  Nat Rev Clin Oncol       Date:  2014-05-20       Impact factor: 66.675

Review 5.  Current role of multiparametric magnetic resonance imaging for prostate cancer.

Authors:  Romaric Loffroy; Olivier Chevallier; Morgan Moulin; Sylvain Favelier; Pierre-Yves Genson; Pierre Pottecher; Gilles Crehange; Alexandre Cochet; Luc Cormier
Journal:  Quant Imaging Med Surg       Date:  2015-10

6.  Diagnostic Performance of Multiparametric MR Imaging at 3.0 Tesla in Discriminating Prostate Cancer from Prostatitis: A Histopathologic Correlation.

Authors:  Elif Peker; Didem Yasemin Sonmez; Habip Eser Akkaya; Serhat Hayme; Memet Ilhan Erden; Ayse Erden
Journal:  Eurasian J Med       Date:  2018-11-30

7.  Targeted Biopsy Validation of Peripheral Zone Prostate Cancer Characterization With Magnetic Resonance Fingerprinting and Diffusion Mapping.

Authors:  Ananya Panda; Gregory OʼConnor; Wei Ching Lo; Yun Jiang; Seunghee Margevicius; Mark Schluchter; Lee E Ponsky; Vikas Gulani
Journal:  Invest Radiol       Date:  2019-08       Impact factor: 6.016

8.  Histologic findings associated with false-positive multiparametric magnetic resonance imaging performed for prostate cancer detection.

Authors:  Jennifer B Gordetsky; David Ullman; Luciana Schultz; Kristin K Porter; Maria Del Carmen Rodriguez Pena; Carli E Calderone; Jeffrey W Nix; Michael Ullman; Sejong Bae; Soroush Rais-Bahrami
Journal:  Hum Pathol       Date:  2018-09-01       Impact factor: 3.466

9.  Prostate cancer GTV delineation with biparametric MRI and 68Ga-PSMA-PET: comparison of expert contours and semi-automated methods.

Authors:  Nathan Hearn; John Blazak; Philip Vivian; Dinesh Vignarajah; Katelyn Cahill; Daisy Atwell; Jim Lagopoulos; Myo Min
Journal:  Br J Radiol       Date:  2021-01-28       Impact factor: 3.039

10.  T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology.

Authors:  Rakesh Shiradkar; Ananya Panda; Patrick Leo; Andrew Janowczyk; Xavier Farre; Nafiseh Janaki; Lin Li; Shivani Pahwa; Amr Mahran; Christina Buzzy; Pingfu Fu; Robin Elliott; Gregory MacLennan; Lee Ponsky; Vikas Gulani; Anant Madabhushi
Journal:  Eur Radiol       Date:  2020-09-02       Impact factor: 5.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.